These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 5398761)

  • 1. [Use of a new estrogen-progestational combination at low doses in gynecologic therapy].
    Seassaro E
    Quad Clin Ostet Ginecol; 1969 Jun; 24(6):385-97. PubMed ID: 5398761
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study of a low dosage estrogen-progestational combination (FH 027-A)].
    Villedieu P
    Rev Fr Gynecol Obstet; 1968 Jun; 63(6):329-36. PubMed ID: 5711745
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental treatment of menopausal disorders by an estrogen-progestogen combination with the estrogen dominant or mixed and then a weak estrogen-progestogen combination].
    Dorangeon P
    Rev Fr Gynecol Obstet; 1974 Jan; 69(1):49-54. PubMed ID: 17436492
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical findings on a new estro-progestinic combination administed at very low doses: ethinyl estradiol-quingestanol acetate].
    Flamigni C; Guerresi E
    Riv Ital Ginecol; 1969 Feb; 53(2):87-123. PubMed ID: 5386488
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of oral contraceptives on glucose tolerance.
    Boshell BR; Roddam RF; McAdams GL; Fox OJ
    J Reprod Fertil Suppl; 1968 Dec; 5():Suppl 5:77-88. PubMed ID: 5288232
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of ethynodiol diacetate, 1 mg, plus ethinyl estradiol, 35 micrograms. A phase IV trial. Introduction.
    Friedman AJ
    J Reprod Med; 1991 Apr; 36(4 Suppl):323-4. PubMed ID: 2046079
    [No Abstract]   [Full Text] [Related]  

  • 7. Further investigations concerning bisecurin, a peroral contraceptive of low hormonal contents.
    Bencsik A
    Ther Hung; 1973; 21(2):79-81. PubMed ID: 4792882
    [No Abstract]   [Full Text] [Related]  

  • 8. [Aspects of hormonal therapy of climacteric cardiopathy associated with ischemic heart disease].
    Kretova NE; Smirnova AA
    Ter Arkh; 1979; 51(8):73-7. PubMed ID: 505308
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biological activities of 3 different types of ethynodiol diacetate-ethynyl estradiol combinations (author's transl)].
    Higashiyama S
    Nihon Funin Gakkai Zasshi; 1978 Oct; 23(4):414-20. PubMed ID: 710724
    [No Abstract]   [Full Text] [Related]  

  • 10. [Our experiences with the long-term use of the oral low-dosage contraceptive Bisecurin].
    Marjanović M; Berić BM
    Med Pregl; 1975; 28(9-10):425-7. PubMed ID: 1186615
    [No Abstract]   [Full Text] [Related]  

  • 11. [Our clinical experience with an ovulostatic estro-progestative combination in weak doses].
    Letessier A; Koressios J
    Gynecol Prat; 1968; 19(3):189-96. PubMed ID: 5720359
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new association of megestrol acetate and ethinyl estradiol in gynecologic therapy. Preliminary results].
    Signorelli I; Emanueli A
    Minerva Ginecol; 1969 Apr; 21(8):512-22. PubMed ID: 5815438
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experience with an estrogen-progestogen association with low estrogen content (ethinodiol-ethinylestradiol)].
    Andreoli C; Fiorentino F; Lenzi G
    Quad Clin Ostet Ginecol; 1970 Jan; 25(1):15-28. PubMed ID: 5523807
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of ethynodiol diacetate with ethinyl estradiol on the mammary glands of rhesus monkeys: a preliminary report.
    Drill VA; Golway PL
    J Natl Cancer Inst; 1978 May; 60(5):1169-70. PubMed ID: 417188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of 17 alpha-ethinyl-trienolone (2 mg) and 17 alpha-ethinyl-estradiol (0,050 mg) in gynecologic therapy].
    Soutoul JH
    Bull Fed Soc Gynecol Obstet Lang Fr; 1968; 20(2):191-4. PubMed ID: 5758158
    [No Abstract]   [Full Text] [Related]  

  • 16. [Developmental trends and conformities in the hormone therapy of climacteric disorders].
    Buschbeck H
    Med Klin; 1967 Sep; 62(37):1432-7. PubMed ID: 4298778
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our clinical experience with ethynodiol diacetate, alone or combined in variable doses with mestranol].
    Colin R
    Gynecol Obstet (Paris); 1966; 65(4):537-43. PubMed ID: 5971381
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical study of Planovine in gynecologic practice].
    Levrier M
    Gynecol Prat; 1971; 22(2):101-10. PubMed ID: 5562316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary experiences with a sequential preparation in the treatment of menopausal complaints.
    Schellen AM; Branolte JH
    Bull Soc R Belge Gynecol Obstet; 1969; 39(3):203-9. PubMed ID: 5399681
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ethynodiol diacetate in gynecologic therapeutics].
    Dumont M
    Lyon Med; 1966 Apr; 215(16):1119-26. PubMed ID: 5930367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.